🧪 Research Focus

We conduct clinical trials to evaluate the safety, feasibility, usability, and efficacy of our neurotechnology systems in real patient populations.
Our focus is on translating laboratory innovations—including neuromodulation, BCI systems, and robotic devices—into clinically validated interventions for motor and cognitive rehabilitation.

We collaborate with hospitals and rehabilitation centers to ensure that our solutions are evidence-based, user-centered, and ready for real-world use.

Background

Developing a novel neurorehabilitation technology is not complete without clinical validation.
To move beyond proof-of-concept, it is essential to:

• Assess patient outcomes using clinical scales (e.g., FMA, MAS, BSST)

• Evaluate system usability from both patients and clinicians

• Monitor neurophysiological changes (EEG/EMG/fMRI) across sessions

• Compare pre- and post-treatment performance over time

Our clinical trials are conducted with:

• Stroke survivors (subacute and chronic)
• Normal control groups for comparative baselines
• Longitudinal designs (e.g., 2–4 weeks of intervention, 3 or more assessment points)
• Multi-center studies when needed, to improve generalizability

Key Research Directions

• Evaluating task-specific motor recovery using robotic glove + EEG/EMG monitoring

• Studying the effect of tACS/tDCS/TIS on motor imagery and neuroplasticity

• Measuring donning time, task performance, and user satisfaction with wearable robots

• Developing clinical BCI protocols that require minimal calibration and are usable by severely impaired patients